Latest Direct To Consumer Sales News

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Globe International increased FY2026 EBIT and net profit despite almost no revenue growth, as a tighter brand portfolio improved margins across all three regions. The ASX-listed group also lifted its fully franked annual dividend to 23 cents per share and ended the year with A$26.7 million in cash.

CONNEQT Health has inked a marketing deal with US longevity platform Blueprint to boost consumer sales of its FDA-cleared Pulse arterial health monitor, targeting health-conscious Americans focused on preventative care.

Lark Distilling Co. reported a 44% jump in net sales to $5 million in Q4 FY26, driven by a booming Global Travel Retail channel and a solid $14.3 million cash reserve. The company’s new Signature Whisky Range supports growth despite flat domestic direct sales.

FlexiRoam has inked a non-binding MoU with a major global telecommunications player to jointly pursue enterprise and MVNO opportunities using its AI-powered eSIM platform, marking a strategic channel expansion.

KMD Brands delivered steady sales growth and margin improvement in Q3 FY26, driven by Kathmandu and Rip Curl, while launching a business review to explore options for accelerating shareholder value.

Cycliq Group’s Q3 FY2026 customer receipts fell 23% year-on-year to $561k, though a late March UpRide Birthday campaign injected $256k in revenue. Operating cash outflows reflect prior quarter cost settlements, with hopes for cost normalisation and sales momentum in Q4.

Decidr AI Industries Ltd (ASX: DAI) reported a doubling of its annualised revenue run rate to A$8.06 million as of March 2026, alongside the launch of its Decidr Agentic Graph platform and significant expansion of its partner ecosystem.

Control Bionics has secured a key regulatory milestone with its NeuroNode device now eligible for reimbursement under Germany’s statutory health insurance, paving the way for expanded European distribution.

Atomos Limited has reported a profitable first half of FY26 with revenue up 28%, driven by strong sales and cost discipline. The company reaffirms its full-year guidance, anticipating further growth and positive cash flow in the second half.

Lark Distilling Co. has reported a solid 10% increase in net sales revenue for the first half of FY26, driven by strong whisky sales and international expansion. The company is gearing up for a major global portfolio launch in the second half, backed by a refreshed brand and enhanced production capacity.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.